Publication & Citation Trends
Publications
0 total
Targeted eHealth Intervention to Reduce Breast Cancer Survivors’ Fear of Recurrence: Results From the FoRtitude Randomized Trial OA
Cited by 58
Semantic Scholar
Abstract CT224: Phase Ib/II, open label, multicenter study of inhaled DV281, a Toll-like receptor 9 agonist, in combination with nivolumab in patients with advanced or metastatic non small cell lung cancer (NSCLC)
Cited by 3
Semantic Scholar
Nivolumab in patients with metastatic DNA mismatch repair deficient/microsatellite instability–high colorectal cancer (CheckMate 142): results of an open-label, multicentre, phase 2 study
Cited by 11
Semantic Scholar
Abstract S1-02: PrECOG 0102: A randomized, double-blind, phase II trial of fulvestrant plus everolimus or placebo in post-menopausal women with hormone receptor (HR)-positive, HER2-negative metastatic breast cancer (MBC) resistant to aromatase inhibitor (AI) therapy
Cited by 43
Semantic Scholar
Efficacy, safety and predictive biomarker results from OAK, a randomized phase III study comparing atezolizumab with docetaxel in patients with advanced NSCLC
Cited by 1
Semantic Scholar
Nivolumab in patients with DNA mismatch repair deficient/microsatellite instability high metastatic colorectal cancer: Update from CheckMate 142.
Cited by 71
Semantic Scholar
Research Topics
Reconstructive Surgery and Microvascular Techniques
(10)
Reconstructive Facial Surgery Techniques
(10)
Cancer Immunotherapy and Biomarkers
(7)
Colorectal Cancer Treatments and Studies
(7)
Nasal Surgery and Airway Studies
(6)
Affiliations
Allina Health
The Barbara Ann Karmanos Cancer Institute
Park Nicollet Clinic
Minnesota Department of Health
L-3 Communications (United States)